The Correlation between Neutrophil Lymphocyte Ratio, C-reactive Protein, and Serum Amyloid a with the Degree of Stenosis in Acute Coronary Syndrome

Authors

  • Edward Kurnia Setiawan Limijadi Department of Clinical Pathology, Faculty of Medical Science, Diponegoro University, Semarang, Indonesia
  • Ariosta Setyadi Department of Clinical Pathology, Faculty of Medical Science, Diponegoro University, Semarang, Indonesia
  • Sulistiyati Bayu Utami Department of Cardiology, Faculty of Medical Science, Diponegoro University, Semarang, Indonesia
  • Buwono Puruhito Department of Physiology, Faculty of Medical Science, Diponegoro University, Semarang, Indonesia
  • Sefri Noventi Sofia Department of Cardiology, Faculty of Medical Science, Diponegoro University, Semarang, Indonesia

DOI:

https://doi.org/10.3889/oamjms.2020.5232

Keywords:

Neutrophil, Lymphocyte, C-reactive protein, Serum Amyloid A, Stenosis, Acute, Coronary

Abstract

BACKGROUND: Inflammation plays a central role in the pathophysiology of acute coronary syndrome (ACS), involving neutrophils as non-specific markers of inflammation and lymphocytes as regulatory markers, measured in the form of neutrophil lymphocyte ratio (NLR). C-reactive protein (CRP) plays a role in the blockage of heart arteries and serum amyloid A (SAA) plays a role in the pathophysiology of coronary stenosis.

AIM: The study aimed to determine the correlation between NLR, CRP, and SAA levels with the degree of coronary artery stenosis in ACS.

METHOD: The design of this study was cross-sectional. The target population in this study was patients with ACS in Dr. Kariadi Hospital Semarang. We performed an NLR measurement with a hematologic analyzer, CRP, and SAA levels using the ELISA method, and coronary angiography using the Gensini score. Furthermore, we also performed the Spearman correlation test between variables.

RESULTS: The median (min; max) values of NLR, CRP, SAA levels, and Gensini score were 4.39 ± 0.48 (0.36; 18.17); 8.63 ± 2.22 (5; 105.11) mg/dL; 36.859 (3.909–69.724); 65 (6–178), respectively. The correlation between NLR, CRP, and SAA levels with the Gensini scores was r = 0.064, p = 0.595; r = 0.240, p = 0.044; r = −0,164, p = 0.171, respectively.

CONCLUSION: CRP measurement could be used as a marker of inflammation in ACS to manage the inflammation process. Furthermore, SAA levels were clinically useful biomolecular parameters in evaluating acute inflammation in ACS, although it did not correlate with the Gensini scores.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Nichols M, Townsend N, Scarborough P, Rayner M. Cardiovascular disease in Europe: Epidemiological update. Eur Heart J. 2013;34(39):3028-34. https://doi.org/10.1093/eurheartj/eht356 PMid:24014390

Santulli G. Epidemiology of Cardiovascular disease in the 21st century: Updated numbers and updated facts. J Cardiovasc Dis. 2013;1:1-2.

Kementerian Kesehatan Republik Indonesia. Riset Kesehatan Dasar (Riskesdas). Indonesia: Kementerian Kesehatan Republik Indonesia. 2013. p. 1-384. https://doi.org/10.36407/akurasi.v2i2.177

Fihn SD, Blankenship JC, Alexander KP, Bittl JA, Byrne JG, Fletcher BJ, et al. 2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: A report of the American college of cardiology/American heart association task force on practice guidelines, and the american association for thoracic surgery, preventive cardiovascular nurses association, society for cardiovascular angiography and interventions, and society of thoracic surgeons. Circulation. 2014;130(19):1749- 67. https://doi.org/10.1161/cir.0000000000000095 PMid:25070666

Tumade B, Jim EL, Joseph F. Prevalensi sindrom koroner akut di RSUP Prof. Dr.R.D. Kandou Manado periode 1 Januari 2014- 31 Desember. J Clin. 2016;4(1):1-6.https://doi.org/10.35790/ecl.4.1.2016.10959

Perhimpunan Dokter Spesialis Kardiovaskular Indonesia. Panduan Praktik Klinis (PPK) dan Clinical Pathway (CP) Penyakit Jantung dan Pembuluh Darah. 1st ed. Jakarta: Perhimpunan Dokter Spesialis Kardiovaskular Indonesia. 2016. p. 1-25. https://doi.org/10.30701/ijc.v35i3.431

Townsend N, Wilson L, Bhatnagar P, Wickramasinghe K, Rayner M, Nichols M, et al. Cardiovascular disease in Europe: Epidemiological update 2016. Eur Heart J. 2016;37(42):3232- 45. https://doi.org/10.1093/eurheartj/ehw334 PMid:27523477

Libby, P. Inflammation in atherosclerosis: From pathophysiology to practice. J Am Coll Cardiol. 2009;54(23):2129-28. PMid:19942084

Habib SS, Masri AA. Relationship of high sensitivity C-reactive protein with presence and severity of coronary artery disease. Pak J Med Sci. 2013;29(6):1425-9. https://doi.org/10.12669/pjms.296.3302 PMid:24550967

Dubey RK, Dhakal N, Das BK, Pandey NK, Baral N, Lamsal MH, et al. C-reactive protein in patients with NSTEMI cute coronary syndrom. J Univ Coll Med Sci. 2013;1(1):10-4. https://doi.org/10.3126/jucms.v1i1.8416

Madjid M, Fatemi O. Components of the complete blood count as risk predictors for coronary heart disease. Tex Heart Inst J. 2013;40(1):17-29. PMid:23467296

Zhan Y, Xu T, Tan X. Two parameters reflect lipid-driven inflammatory state in acute coronary syndrome: Atherogenic index of plasma, neutrophil-lymphocyte ratio. BMC Cardiovasc Disord. 2016;16:96. https://doi.org/10.1186/s12872-016-0274-7 PMid:27188383

Targońska-Stępniak B, Majdan M. Serum amyloid a as a marker of persistent inflammation and an indicator of cardiovascular and renal involvement in patients with rheumatoid arthritis. Mediators Inflamm. 2014;2014:793628.https://doi.org/10.1155/2014/793628

Siegmund SV, Schlosser TM, Schildberg FA, Seki F, Minicis SD, Uchinami H, et al. Serum amyloid a induces inflammation, proliferation and cell death in activated hepatic stellate cells. PLoS One. 2016;11(3):e0150893. https://doi.org/10.1371/journal.pone.0150893 PMid:26937641

Sudana IN, Setyawati S, Sukorini U. Perbedaan bermakna kadar serum amiloid a antara stenosis koroner dibandingkan bukan stenosis koroner. Indones J Clin Pathol Med Lab. 2015;21(3):231-6. https://doi.org/10.24293/ijcpml.v21i3.1273

Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A, et al. 2013 ESC guidelines on the management of stable coronary artery disease: The task force on the management of stable coronary artery disease of the European society of cardiology. Eur Heart J. 2013;34(38):2949-3003. https://doi.org/10.1093/eurheartj/eht296 PMid:23996286

Lennep JE, Westerveld HT, Erkelens DW, Wall EE. Risk factors for coronary heart disease: Implications of gender. Cardiovasc Res. 2002;53:538-49. PMid:11861024

Michael TJ, George P. Diabetes mellitus and heart disease. In: Diabetes and Cardiovascular Disease. 2nd ed. Totowa, New Jersey: Humana Press Inc.; 2008.

Pacheco HG, Barron JV, Vallejo M, Reyna YP, Castillo AA, Tapia PS, et al. Prevalence of conventional risk factors and lipid profiles in patients with acute coronary syndrome and significant coronary disease. Ther Clin Risk Manag. 2014;10:815-23. https://doi.org/10.2147/tcrm.s67945 PMid:25328397

Shrivastava A, Harsh V, Raizada A, Singh SK. C-reactive protein, inflammation and coronary heart disease. Egypt Heart J. 2015;67(2):89-97. https://doi.org/10.1016/j.ehj.2014.11.005

Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol. 1983;51(3):606. https://doi.org/10.1016/s0002-9149(83)80105-2 PMid:6823874

Li X, Ji Y, Kang J, Fang N. Association between blood neutrophil-to-lymphocyte ratio and severity of coronary artery disease. Medicine (Baltimore). 2018;97(39):e12432. https://doi.org/10.1097/md.0000000000012432 PMid:30278521

Ridker PM. High-sensitivity C-reactive protein: Potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation. 2001;103(13):1813-8. https://doi.org/10.1161/01.cir.103.13.1813 PMid:11282915

Goff D, Donald M, Bennet G, Coady S, D’Agostino RB, Gibbons R, et al. ACC/AHA guidelines on the assessment of cardiovascular risk. Circulation. 2014;129 Suppl 2:S49-73. PMid:24222018

Habib SS, Al Masri AA. Relationship of high sensitivity C-reactive protein (hs-CRP) with presence and severity of coronary artery disaese. Pak J Med Sci. 2013;29(6):1425-9. https://doi.org/10.12669/pjms.296.3302

Mansoor A, Baloch DJ, Memon F, Khan MU, Shafique M, Ali A. Pattern of coronary atherosclerosis in smokers and non-smokers. Pak Heart J. 2003;36:20-5. Available from: https://www.pkheartjournal.com/index.php/pkheart/article/view/83/80.

Malle E, Beer FC.Human serum amyloid A (SAA) protein: A prominent acute-phase reactant for clinical practice. Eur J Clin Invest. 2016;26(6):427-35. https://doi.org/10.1046/j.1365-2362.1996.159291.x PMid:8817153

Kotani K, Satoh N, Yamada T, Gugliucci A. The potential of serum amyloid A-LDL as a novel biomarker for cardiovascular disease risk. Clin Lipidol. 2010;5(4):489-95. https://doi.org/10.2217/clp.10.42

Downloads

Published

2020-12-01

How to Cite

1.
Limijadi EKS, Setyadi A, Utami SB, Puruhito B, Sofia SN. The Correlation between Neutrophil Lymphocyte Ratio, C-reactive Protein, and Serum Amyloid a with the Degree of Stenosis in Acute Coronary Syndrome. Open Access Maced J Med Sci [Internet]. 2020 Dec. 1 [cited 2023 Feb. 4];8(B):1234-9. Available from: https://oamjms.eu/index.php/mjms/article/view/5232

Most read articles by the same author(s)